Abstract LB198: CETSA-driven targeted proteomics for personalized AML therapies: Investigating drug response biomarkers and resistance mechanisms
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Anderson Daniel Ramos, Smaranda Bacanu, Sara Lööf, Sofia Bengtzén, Jiawen Lyu, Sören Lehmann, Pär Nordlund
Institution: Karolinska Institutet
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409821258